Valeant announces sale of iNova Pharmaceuticals for $930 million
Valeant Pharmaceuticals has entered into an agreement to sell its…
Valeant Pharmaceuticals has entered into an agreement to sell its iNova Pharmaceuticals business for $930 million in cash.